Ventriculovascular coupling in systolic and diastolic heart failure

Justin M Fox1, Mathew S Maurer

  • 1Clinical Cardiovascular Research Laboratory for the Elderly, Allen Pavilion of New York Presbyterian Hospital, 5141 Broadway, 3 Field West, Room 035, New York, NY 10034, USA.

Insights

Ventricular mechanics and ventriculovascular coupling are key to understanding heart failure (HF). Abnormal coupling may drive HF with preserved ejection fraction, offering new therapeutic targets.

Area of Science:

  • Cardiovascular Physiology
  • Heart Failure Pathophysiology
  • Ventriculovascular Mechanics

Background:

  • Pressure-volume analysis is crucial for understanding ventricular mechanics and heart failure mechanisms.
  • Recent research highlights the role of heart rate control, blood pressure lability, and pulmonary edema in heart failure.
  • Ventriculovascular coupling, the interaction between the left ventricle and arterial system, is gaining renewed attention.

Purpose of the Study:

  • To investigate the role of ventriculovascular coupling in the development of heart failure.
  • To explore abnormal ventriculovascular coupling as a potential mechanism in heart failure with normal ejection fraction.
  • To identify novel therapeutic targets for heart failure based on ventriculovascular coupling.

Main Methods:

  • Utilizing pressure-volume analysis to assess ventricular function.
  • Analyzing recent investigations on heart rate control, blood pressure lability, and pulmonary edema.
  • Correlating findings with the pathophysiology of heart failure with normal ejection fraction.

Main Results:

  • Abnormal ventriculovascular coupling is implicated in the development of heart failure.
  • This coupling dysfunction may be a significant factor in heart failure with normal ejection fraction.
  • Insights suggest potential for new therapeutic strategies targeting ventriculovascular interactions.

Conclusions:

  • Ventriculovascular coupling is a critical determinant of cardiac function and heart failure progression.
  • Dysfunctional ventriculovascular coupling represents a key pathophysiological mechanism in heart failure with normal ejection fraction.
  • Targeting ventriculovascular coupling may offer novel therapeutic avenues for heart failure management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiac Cycle01:29

Cardiac Cycle

The cardiac cycle refers to the sequence of events that occur in the heart from the beginning of one heartbeat to the next. It's characterized by alternating periods of contraction (systole) and relaxation (diastole) of the heart muscles.
During the cardiac cycle, blood flow through the heart is regulated entirely by changing pressure gradients. This sequence of events begins with the heart in a state of total relaxation, known as mid-to-late diastole, during which blood passively flows from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...